查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954598

全球自体输血装置市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测（2026-2034 年）

Autotransfusion Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 141 Pages | 商品交期: 请询问到货日

价格

自体输血装置市场成长驱动因素

2025 年全球自体输血装置市场规模为 3.2961 亿美元，预计 2026 年将成长至 3.5097 亿美元。到 2034 年，该市场预计将达到 5.9049 亿美元，在预测期（2026-2034 年）内，复合年增长率 (CAGR) 为 6.72%。

北美将在 2025 年以 49.76% 的市场占有率引领全球市场，这主要得益于心血管和骨科手术的增加、完善的医疗基础设施以及促进术中和术后自体输血实践的成熟临床指南。输血。

自体输血（也称为自体血液回收系统）允许患者在手术期间重新输注自身血液，从而减少对供血者的依赖。这无需进行交叉配血试验，最大限度地减少输血反应，并降低感染风险。这些系统广泛应用于心血管、骨科、神经外科、妇产科和其他大型外科手术。

市场动态

市场驱动因素

手术数量不断增加

受心臟病和神经系统疾病等慢性病发病率上升的推动，全球大型外科手术的数量正在增加。术中和术后自体血液回收在血液保存策略中发挥着至关重要的作用。

根据美国关节登记处（2023 年）的数据，美国每年约有 320 万例髋关节和膝关节置换手术。器官移植手术数量的增加也推动了市场成长。 2023 年，美国共进行了 46,632 例器官移植手术，比 2022 年增加了 8.7%。

此外，老年人口的增长以及慢性疾病的易感性，也推动了术中对先进血液管理系统的需求增长。

市场限制因子

微创手术日益普及

微创手术因其住院时间短、成本低、出血量少等优点而越来越受欢迎。由于这些手术出血量有限，对自体输血装置的需求可能会降低。此外，先进止血装置的研发将进一步减少出血量，这可能会限制自体输血系统的应用。

市场机会

血液供需缺口

已开发国家和新兴国家捐血者短缺日益严重，这带来了巨大的市场机会。在中国，过去十年血液供应量增加了7.0%，而手术量却增加了18.0%，造成了供需缺口。自体输血系统为弥合此供需失衡提供了一个可靠的解决方案。

市场挑战

产品成本高且技术复杂可能会限制其在新兴经济体的应用。此外，在受污染的手术区域感染的风险可能会限制该装置在某些手术中的使用。

市场趋势

技术进步

持续的技术创新是关键的市场趋势。 2022年9月，Atlanpol Biotherapeutics的i-SEP自体输血装置获得CE认证，该装置能够回收红血球和血小板。 2023年3月，Hemonetics的下一代智慧控制软体获得美国FDA批准，用于CellSaver Elite Plus系统，可提高操作效率和使用者体验。

市场区隔分析

依产品类型

市场依产品类型分为自体输血系统及耗材及配件。

到2026年，耗材及配件细分市场将占主导地位，市场占有率达58.10%，这主要得益于频繁的更换需求和手术数量的增加。

由于人们对自体输血益处的认识不断提高，包括术中、术后和双模式系统在内的自体输血系统预计将稳步增长。自体输血。

依应用领域划分

应用领域包括心血管外科、骨科、神经外科和妇科手术。

2024年，心血管外科领域以60.11%的市占率领先，主要受冠状动脉绕道手术（CABG）和瓣膜置换术等大出血手术的推动。骨科占第二大市场占有率，而神经外科和妇产科预计将温和成长。

依最终使用者划分

市场分为医院和专科诊所。

2026年，医院将占主导地位，市场占有率达89.67%，主要受医院进行的大型手术数量众多所驱动。由于细胞回收技术的日益普及，专科诊所预计将保持稳定成长。

区域概览

北美

2025年北美市场规模为1.6403亿美元，预计2026年将达到1.7485亿美元。美国市场预计2026年将达到1.6063亿美元。强有力的监管支持和完善的血液管理指南正在推动该地区的成长。

欧洲

由于手术数量的增加和公众意识的提高，欧洲市场呈现稳定成长态势。

  • 英国市场：到2026年达到2,170万美元
  • 德国市场：到2026年达到3,261万美元

亚太地区

预计亚太地区市场到2034年将维持显着的复合年增长率。

  • 日本：到2026年达到1224万美元
  • 中国：到2026年达到1175万美元
  • 印度：到2026年达到380万美元

医疗基础设施的扩建和医院数量的增加正在推动这一增长。

世界其他地区

巴西、沙乌地阿拉伯和阿拉伯联合大公国等国的手术数量增加，促进了该地区手术量的稳定成长。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要国家心血管手术数量（2025 年）
  • 主要全国骨科手术数量（2025 年）
  • 主要国家妇科手术数量（2025 年）
  • 主要产业趋势：併购、商业联盟、新产品与服务介绍
  • 新冠疫情对市场的影响

第五章 全球自体输血设备市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品类型划分
    • 自体输血系统
      • 术中自体输血系统
      • 术后自体输血系统
      • 双模式自体输血系统
    • 耗材及配件
  • 市场分析、洞察与预测：依应用领域划分
    • 心臟输血手术
    • 骨科手术
    • 神经外科手术
    • 妇产科手术
    • 其他
  • 市场分析、洞察与预测：依最终用户划分
    • 医院
    • 专科诊所及其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 世界其他地区

第六章 北美自体输血装置市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲自体输血装置市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国王国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 其他欧洲国家

第八章 亚太地区自体输血装置市场分析：洞察与预测（2021-2034）

  • 国家细分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 其他亚太地区

第九章 世界其他地区（ROW）自体输血装置市场分析：洞察与预测（2021-2034）

第10章 竞争分析

  • 全球市场占有率分析(2025年)
  • 企业简介
    • Haemonetics Corporation
    • LivaNova PLC
    • Medtronic
    • Fresenius SE &Co. KGaA
    • BD
    • Beijing Jingjing Medical Equipment Co., Ltd.
    • ProCell Surgical Inc.
Product Code: FBI101899

Growth Factors of autotransfusion devices Market

The global autotransfusion devices market was valued at USD 329.61 million in 2025 and is projected to grow to USD 350.97 million in 2026. The market is expected to reach USD 590.49 million by 2034, registering a CAGR of 6.72% during the forecast period (2026-2034).

North America dominated the global market with a 49.76% share in 2025, driven by the increasing number of cardiovascular and orthopedic surgeries, strong healthcare infrastructure, and established clinical guidelines promoting intraoperative and post-operative autotransfusion practices.

Autotransfusion, also known as a cell saver system, allows patients to receive their own blood during surgery, reducing dependence on donor blood. It eliminates cross-matching requirements, minimizes transfusion reactions, and lowers infection risks. These systems are widely used in cardiovascular, orthopedic, neurological, obstetrics & gynecological, and other major surgical procedures.

Market Dynamics

Market Drivers

Rising Number of Surgical Procedures

The growing prevalence of chronic diseases such as cardiac and neurological disorders has increased the number of major surgical procedures globally. Intraoperative and post-operative cell salvage plays a crucial role in blood conservation strategies.

According to the American Joint Replacement Registry (2023), approximately 3.2 million hip and knee arthroplasty procedures were recorded in the U.S. Rising transplant surgeries further support market growth. In 2023, 46,632 organ transplants were performed in the U.S., reflecting an 8.7% increase from 2022.

Additionally, the expanding geriatric population, which is more susceptible to chronic diseases, is increasing demand for advanced blood management systems during surgeries.

Market Restraints

Growing Preference for Minimally Invasive Surgeries

Minimally invasive procedures are gaining popularity due to shorter hospital stays, lower costs, and reduced blood loss. Since these surgeries involve limited bleeding, the need for autotransfusion devices may decline. Moreover, the development of advanced hemostatic devices further reduces blood loss, limiting the adoption of autotransfusion systems.

Market Opportunities

Gap Between Blood Demand and Supply

The increasing shortage of donor blood in both developed and emerging countries presents a significant opportunity. Although blood supply in China grew by 7.0% over the past decade, surgical procedures increased by 18.0%, creating a supply-demand gap. Autotransfusion systems provide a reliable solution to address this imbalance.

Market Challenges

High product costs and technological complexities may limit adoption in emerging economies. Additionally, the risk of infection in contaminated surgical fields may restrict device usage in certain procedures.

Market Trends

Technological Advancements

Continuous innovation is a key market trend. In September 2022, Atlanpole Biotherapies received CE approval for its i-SEP autotransfusion device capable of recovering both red blood cells and platelets.

In March 2023, Haemonetics Corporation received U.S. FDA clearance for next-generation Intelligent Control software for the Cell Saver Elite+ system, enhancing operational efficiency and user experience.

Segmentation Analysis

By Product Type

The market is segmented into autotransfusion systems and consumables & accessories.

The consumables & accessories segment dominated in 2026 with a 58.10% share, driven by frequent replacement needs and increasing surgical volumes.

Autotransfusion systems, including intraoperative, post-operative, and dual-mode systems, are projected to grow steadily due to rising awareness of autologous blood transfusion benefits.

By Application

Applications include cardiovascular, orthopedic, neurological, obstetrics & gynecological surgeries, and others.

The cardiovascular surgeries segment led the market, accounting for 60.11% share in 2024, due to high blood loss procedures such as CABG and valve replacements. Orthopedic surgeries held the second-largest share, while neurological and OB/GYN surgeries are expected to grow at moderate rates.

By End User

The market is divided into hospitals and specialty clinics.

The hospitals segment dominated in 2026 with an 89.67% share, supported by the high volume of major surgeries performed in hospital settings. Specialty clinics are projected to grow steadily with increasing adoption of cell salvage technologies.

Regional Insights

North America

North America accounted for USD 164.03 million in 2025 and is projected to reach USD 174.85 million in 2026. The U.S. market is expected to reach USD 160.63 million in 2026. Strong regulatory support and established blood management guidelines drive regional growth.

Europe

Europe is experiencing steady growth due to rising surgical procedures and increased awareness.

  • UK market: USD 21.7 million by 2026
  • Germany market: USD 32.61 million by 2026

Asia Pacific

Asia Pacific is projected to grow at a significant CAGR through 2034.

  • Japan: USD 12.24 million by 2026
  • China: USD 11.75 million by 2026
  • India: USD 3.8 million by 2026

Expanding healthcare infrastructure and increasing hospital numbers support growth.

Rest of the World

Countries such as Brazil, Saudi Arabia, and the UAE are witnessing rising surgical volumes, contributing to steady regional growth.

Competitive Landscape

The market is highly consolidated, with key players including LivaNova PLC, Haemonetics Corporation, Fresenius SE & Co. KGaA, Medtronic, BD, Beijing Jingjing Medical Equipment Co., and ProCell Surgical Inc.

Companies are focusing on regulatory approvals, partnerships, and product innovation to strengthen their global presence.

Conclusion

The global autotransfusion devices market is set to grow from USD 329.61 million in 2025 to USD 590.49 million by 2034, driven by increasing surgical volumes, rising organ transplants, technological advancements, and the need to address blood supply shortages. North America remains the dominant region, while Asia Pacific presents strong growth opportunities. Despite challenges such as high costs and the rise of minimally invasive surgeries, continued innovation and expanding healthcare infrastructure are expected to sustain steady market expansion through 2034.

Segmentation By Product Type

  • Autotransfusion Systems
    • Intraoperative Autotransfusion Systems
    • Post-operative Autotransfusion Systems
    • Dual-Mode Autotransfusion Systems
  • Consumables & Accessories

By Application

  • Cardiovascular Surgeries
  • Orthopedic Surgeries
  • Neurological Surgeries
  • Obstetrics & Gynecological Surgeries
  • Others

By End User

  • Hospitals
  • Specialty Clinics & Others

By Region

  • North America (By Product Type, By Application, By End User, and By Country)
    • U.S. (By Application)
    • Canada (By Application)
  • Europe (By Product Type, By Application, By End User, and By Country/Sub-Region)
    • U.K. (By Application)
    • Germany (By Application)
    • France (By Application)
    • Italy (By Application)
    • Spain (By Application)
    • Scandinavia (By Application)
    • Rest of Europe (By Application)
  • Asia Pacific (By Product Type, By Technology, By End User, and By Country/Sub-Region)
    • Japan (By Application)
    • China (By Application)
    • India (By Application)
    • Australia (By Application)
    • Southeast Asia (By Application)
    • Rest of Asia Pacific (By Application)
  • Rest of the World (By Product Type, By Application, By End User)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Cardiovascular Surgeries, By Key Countries, 2025
  • 4.2. Number of Major Orthopedic Surgeries, By Key Countries, 2025
  • 4.3. Number of Major Obstetrics & Gynecological Surgeries, By Key Countries, 2025
  • 4.4. Key Industry Developments - Mergers, Acquisitions, Partnerships, and Launches
  • 4.5. Impact of COVID-19 on the Market

5. Global Autotransfusion Devices Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast- By Product Type
    • 5.1.1. Autotransfusion Systems
      • 5.1.1.1. Intraoperative Autotransfusion Systems
      • 5.1.1.2. Postoperative Autotransfusion Systems
      • 5.1.1.3. Dual-mode Autotransfusion Systems
    • 5.1.2. Consumables & Accessories
  • 5.2. Market Analysis, Insights and Forecast- By Application
    • 5.2.1. Cardiovascular Surgeries
    • 5.2.2. Orthopedic Surgeries
    • 5.2.3. Neurological Surgeries
    • 5.2.4. Obstetrics & Gynecological Surgeries
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast- By End-user
    • 5.3.1. Hospital
    • 5.3.2. Specialty Clinics & Others
  • 5.4. Market Analysis, Insights and Forecast- By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Rest of the World

6. North America Autotransfusion Devices Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Autotransfusion Systems
      • 6.1.1.1. Intraoperative Autotransfusion Systems
      • 6.1.1.2. Postoperative Autotransfusion Systems
      • 6.1.1.3. Dual-mode Autotransfusion Systems
    • 6.1.2. Consumables & Accessories
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Cardiovascular Surgeries
    • 6.2.2. Orthopedic Surgeries
    • 6.2.3. Neurological Surgeries
    • 6.2.4. Obstetrics & Gynecological Surgeries
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Hospital
    • 6.3.2. Specialty Clinics & Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. By Application
    • 6.4.2. Canada
      • 6.4.2.1. By Application

7. Europe Autotransfusion Devices Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Autotransfusion Systems
      • 7.1.1.1. Intraoperative Autotransfusion Systems
      • 7.1.1.2. Postoperative Autotransfusion Systems
      • 7.1.1.3. Dual-mode Autotransfusion Systems
    • 7.1.2. Consumables & Accessories
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Cardiovascular Surgeries
    • 7.2.2. Orthopedic Surgeries
    • 7.2.3. Neurological Surgeries
    • 7.2.4. Obstetrics & Gynecological Surgeries
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Hospital
    • 7.3.2. Specialty Clinics & Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. U.K.
      • 7.4.1.1. By Application
    • 7.4.2. Germany
      • 7.4.2.1. By Application
    • 7.4.3. France
      • 7.4.3.1. By Application
    • 7.4.4. Spain
      • 7.4.4.1. By Application
    • 7.4.5. Italy
      • 7.4.5.1. By Application
    • 7.4.6. Scandinavia
      • 7.4.6.1. By Application
    • 7.4.7. Rest of Europe
      • 7.4.7.1. By Application

8. Asia Pacific Autotransfusion Devices Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Autotransfusion Systems
      • 8.1.1.1. Intraoperative Autotransfusion Systems
      • 8.1.1.2. Postoperative Autotransfusion Systems
      • 8.1.1.3. Dual-mode Autotransfusion Systems
    • 8.1.2. Consumables & Accessories
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Cardiovascular Surgeries
    • 8.2.2. Orthopedic Surgeries
    • 8.2.3. Neurological Surgeries
    • 8.2.4. Obstetrics & Gynecological Surgeries
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Hospital
    • 8.3.2. Specialty Clinics & Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. Japan
      • 8.4.1.1. By Application
    • 8.4.2. China
      • 8.4.2.1. By Application
    • 8.4.3. India
      • 8.4.3.1. By Application
    • 8.4.4. Australia
      • 8.4.4.1. By Application
    • 8.4.5. Southeast Asia
      • 8.4.5.1. By Application
    • 8.4.6. Rest of Asia Pacific
      • 8.4.6.1. By Application

9. Rest of the World Autotransfusion Devices Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Autotransfusion Systems
      • 9.1.1.1. Intraoperative Autotransfusion Systems
      • 9.1.1.2. Postoperative Autotransfusion Systems
      • 9.1.1.3. Dual-mode Autotransfusion Systems
    • 9.1.2. Consumables & Accessories
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Cardiovascular Surgeries
    • 9.2.2. Orthopedic Surgeries
    • 9.2.3. Neurological Surgeries
    • 9.2.4. Obstetrics & Gynecological Surgeries
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Hospital
    • 9.3.2. Specialty Clinics & Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. Haemonetics Corporation
      • 10.2.1.1. Overview
      • 10.2.1.2. Products & services
      • 10.2.1.3. SWOT Analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. Financials (Based on Availability)
    • 10.2.2. LivaNova PLC
      • 10.2.2.1. Overview
      • 10.2.2.2. Products & services
      • 10.2.2.3. SWOT Analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. Financials (Based on Availability)
    • 10.2.3. Medtronic
      • 10.2.3.1. Overview
      • 10.2.3.2. Products & services
      • 10.2.3.3. SWOT Analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. Financials (Based on Availability)
    • 10.2.4. Fresenius SE & Co. KGaA
      • 10.2.4.1. Overview
      • 10.2.4.2. Products & services
      • 10.2.4.3. SWOT Analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. Financials (Based on Availability)
    • 10.2.5. BD
      • 10.2.5.1. Overview
      • 10.2.5.2. Products & services
      • 10.2.5.3. SWOT Analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. Financials (Based on Availability)
    • 10.2.6. Beijing Jingjing Medical Equipment Co., Ltd.
      • 10.2.6.1. Overview
      • 10.2.6.2. Products & services
      • 10.2.6.3. SWOT Analysis
      • 10.2.6.4. Recent Developments
      • 10.2.6.5. Strategies
      • 10.2.6.6. Financials (Based on Availability)
    • 10.2.7. ProCell Surgical Inc.
      • 10.2.7.1. Overview
      • 10.2.7.2. Products & services
      • 10.2.7.3. SWOT Analysis
      • 10.2.7.4. Recent Developments
      • 10.2.7.5. Strategies
      • 10.2.7.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Autotransfusion Devices Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 2: Global Autotransfusion Devices Market Revenue (USD million) Forecast, by Autotransfusion Systems, 2021-2034
  • Table 3: Global Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 4: Global Autotransfusion Devices Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 5: Global Autotransfusion Devices Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 6: North America Autotransfusion Devices Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 7: North America Autotransfusion Devices Market Revenue (USD million) Forecast, by Autotransfusion Systems, 2021-2034
  • Table 8: North America Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 9: North America Autotransfusion Devices Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 10: North America Autotransfusion Devices Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 11: U.S. Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 12: Canada Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 13: Europe Autotransfusion Devices Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 14: Europe Autotransfusion Devices Market Revenue (USD million) Forecast, by Autotransfusion Systems, 2021-2034
  • Table 15: Europe Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 16: Europe Autotransfusion Devices Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 17: Europe Autotransfusion Devices Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 18: U.K. Autotransfusion Devices Market Revenue (USD million) Forecast, by Autotransfusion Systems, 2021-2034
  • Table 19: Germany Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 20: France Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 21: Italy Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 22: Spain Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 23: Scandinavia Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 24: Rest of Europe Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 25: Asia Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 26: Asia Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, by Autotransfusion Systems, 2021-2034
  • Table 27: Asia Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 28: Asia Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 29: Asia Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 30: China Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 31: India Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 32: Japan Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 33: Australia Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 34: Southeast Asia Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 35: Rest of Asia Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 36: Rest of the World Autotransfusion Devices Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 37: Rest of the World Autotransfusion Devices Market Revenue (USD million) Forecast, by Autotransfusion Systems, 2021-2034
  • Table 38: Rest of the World Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 39: Rest of the World Autotransfusion Devices Market Revenue (USD million) Forecast, by End-user, 2021-2034

List of Figures

  • Figure 1: Global Autotransfusion Devices Market Revenue Breakdown (USD million, %) By Region, 2025 & 2034
  • Figure 2: Global Autotransfusion Devices Market Value Share (%), By Product Type, 2025 & 2034
  • Figure 3: Global Autotransfusion Devices Market Value Share (%), By Application, 2025 & 2034
  • Figure 4: Global Autotransfusion Devices Market Value Share (%), By End-user, 2025 & 2034
  • Figure 5: Global Autotransfusion Devices Market Value (USD million), By Region, 2025 & 2034
  • Figure 6: North America Autotransfusion Devices Market Value (USD million), By Product Type, 2025 & 2034
  • Figure 7: North America Autotransfusion Devices Market Value Share (%), By Product Type, 2025
  • Figure 8: North America Autotransfusion Devices Market Value (USD million), By Application, 2025 & 2034
  • Figure 9: North America Autotransfusion Devices Market Value Share (%), By Application, 2025
  • Figure 10: North America Autotransfusion Devices Market Value (USD million), By End-user, 2025 & 2034
  • Figure 11: North America Autotransfusion Devices Market Value Share (%), By End-user, 2025
  • Figure 12: North America Autotransfusion Devices Market Value (USD million), By Country, 2025 & 2034
  • Figure 13: North America Autotransfusion Devices Market Value Share (%), By Country, 2025
  • Figure 14: Europe Autotransfusion Devices Market Value (USD million), By Product Type, 2025 & 2034
  • Figure 15: Europe Autotransfusion Devices Market Value Share (%), By Product Type, 2025
  • Figure 16: Europe Autotransfusion Devices Market Value (USD million), By Application, 2025 & 2034
  • Figure 17: Europe Autotransfusion Devices Market Value Share (%), By Application, 2025
  • Figure 18: Europe Autotransfusion Devices Market Value (USD million), By End-user, 2025 & 2034
  • Figure 19: Europe Autotransfusion Devices Market Value Share (%), By End-user, 2025
  • Figure 20: Europe Autotransfusion Devices Market Value (USD million), By Country/ Sub-Region, 2025 & 2034
  • Figure 21: Europe Autotransfusion Devices Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 22: Asia Pacific Autotransfusion Devices Market Value (USD million), By Product Type, 2025 & 2034
  • Figure 23: Asia Pacific Autotransfusion Devices Market Value Share (%), By Product Type, 2025
  • Figure 24: Asia Pacific Autotransfusion Devices Market Value (USD million), By Application, 2025 & 2034
  • Figure 25: Asia Pacific Autotransfusion Devices Market Value Share (%), By Application, 2025
  • Figure 26: Asia Pacific Autotransfusion Devices Market Value (USD million), By End-user, 2025 & 2034
  • Figure 27: Asia Pacific Autotransfusion Devices Market Value Share (%), By End-user, 2025
  • Figure 28: Asia Pacific Autotransfusion Devices Market Value (USD million), By Country/ Sub-Region, 2025 & 2034
  • Figure 29: Asia Pacific Autotransfusion Devices Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 30: Rest of the World Autotransfusion Devices Market Value (USD million), By Product Type, 2025 & 2034
  • Figure 31: Rest of the World Autotransfusion Devices Market Value Share (%), By Product Type, 2025
  • Figure 32: Rest of the World Autotransfusion Devices Market Value (USD million), By Application, 2025 & 2034
  • Figure 33: Rest of the World Autotransfusion Devices Market Value Share (%), By Application, 2025
  • Figure 34: Rest of the World Autotransfusion Devices Market Value (USD million), By End-user, 2025 & 2034
  • Figure 35: Rest of the World Autotransfusion Devices Market Value Share (%), By End-user, 2025
  • Figure 36: Global Autotransfusion Devices Market Share (%), By Company, 2025